A new study backed by ingredient supplier OmniActive Health Technologies elucidated further the mechanism in which macular carotenoids may protect eyes from blue light damage.
Kiwi firm Unipharm's DHA algal oil candy, as well as a range of its other supplements, successfully entered China's brick-and-mortar stores last month.
A Tasmanian dairy which is said to have launched the world's first yogurt made from milk containing naturally occurring omega-3 is seeing sales growing by 30% year-on-year — and it is now targeting exports to Asia.
Health & Happiness International (H&H, formerly Biostime International) has now launched its $350m dual-currency loan from Goldman Sachs into limited syndication.
Singapore-based supplement firm Senescence Life Sciences is seeking to collaborate with major industry players to advance its work around cognitive health in the region.
Do we need precise nutrition or a generally nutritional diet to achieve good health in old age? A group of panellists expressed differing views at the first Healthy Ageing APAC Summit, organised by NutraIngredients-Asia and FoodNavigator-Asia.
Allergen-Free Foods, an arm of Nikkoh Co., is targeting growth with free-from chocolates after establishing an independent factory to develop products that do not contain 27 types of allergens.
"We are very sorry about the difficulties that some parents have had," says Danone
Danone says it is looking into reports that its newly reformulated Aptamil baby milk formula is making some infants ill, after hundreds of complaints from parents in the UK.
China's 'new retail' phenomenon — whereby companies like Alibaba seek to converge e-commerce insights with bricks-and-mortar retail operations — could provide as many opportunities for supplement brands as it has done for food firms, Blackmores...
The number of muscle health products is likely to grow in APAC as the region ages and consumers become better educated about conditions such as sarcopenia.
Yashili has announced deals in China and New Zealand to strengthen supply and service agreements with two of its biggest shareholders, Mengniu and Danone, while also bolstering its relationship with Australia's Burra Foods.
Health & Happiness International (H&H, formerly Biostime International) — and owner of Swisse — has announced it is seeking a loan of up to US$350m through Goldman Sachs.
TSI's Australia MD Ross Norris urged firms operating in China to diversify their sales channels, such as venturing into domestic manufacturing and trade, instead of betting all stakes on e-commerce.
BASF's human nutrition brand Newtrition has gained exclusive distribution rights to market Aussie consumer healthcare firm Xerion's omega-3 test kits, thanks to a new three-year agreement between the two companies.
Fonterra has denied allegations that its China partner Beingmate's infant formula contains additives from unlicensed suppliers, insisting that recent case was a 'technical issue' and not a food safety issue.
There is compelling evidence to back supplementation with omega-3, vitamin D and macular carotenoids to improve health outcomes as people age, according to the head of the Blackmores Institute.
The Mead Johnson-Reckitt Benckiser merger has filed two international patents for formulations with dietary butyrate, which it says can improve brain development and reduce metabolic syndrome in infants.
Japanese herbal outfit Tsumura & Co has established a joint venture with Ping An Insurance (Group) Company of China in an attempt to strengthen the quality of TCM-based products.
Finless Foods' CSO and co-founder Brian Wyrwas says the firm is making considerable progress in slashing production costs for lab-grown fish, claiming "there is continuous progress every single day to get to price parity with Bluefin tuna".
Swisse is harnessing the power of a little-known plant called Andrographis paniculata to relieve symptoms of the common cold and provide immune support.
Nestlé Japan has announced plans to branch out from the food and beverage business into healthcare, with personalised nutrition and aged care a prominent feature of this shift.
Innovation Network Corporation of Japan (INCJ) and Mitsubishi Corporation (MC) have invested 1.7 billion yen in Spirulina manufacturer Tavelmout Corporation.
Asia Pacific’s rapidly ageing population will drive significant opportunities for the region’s food and nutrition industry, according to keynote speakers on day one of the inaugural event in Singapore.
Australian supplement firm Bod Australia will see George Livery — Swisse's former strategy and corporate director — join its ranks as executive chairman in September this year to drive the firm’s growth strategy in supplements and medical cannabis...
Infant formula firm Bubs Australia has entered a binding manufacturing agreement with a CNCA-licensed production facility as part of its efforts to achieve CFDA (China Food and Drug Administration) registration, while also inking a deal with Alibaba to...
Machine-based learning could be as effective as the human ear when it comes to detecting infant crying or fussing, opening up possibilities for potential clinical applications such as detecting colic.
Bubs Australia has signed a supply agreement with New Times Asia, a China-based supply chain and service provider, which will lead to a significant increase in its distribution in the country.
Customer service, environmental consciousness and constant innovation are crucial to longevity in the health and nutrition industry, according to Blackmores managing director Dave Fenlon.
Indian firm Zydus Wellness is seeking to tap to into the country's food fortification drive by launching an egg-free mayonnaise called Nutralite, fortified with vitamins A, D and E.
Morinaga Milk's financial results for the last year saw a slight dip overall, with net sales falling 0.1% (¥530m) year-on-year to ¥592,087m, but the firm is targeting sales success with its higher-value functional products.
Bega Bionutrients, the health and ingredient arm of Australian firm Bega Cheese, has launched a novel form of microencapsulated infant formula ingredient lactoferrin – Inferrin.
A supplement containing a proprietary hop flower extract from New Zealand is entering the US market, positioned for weight management through appetite control.
Indian pharmaceutical firm Sundyota Numandis will open a US$12m probiotic facility to meet demand, following link-ups with major industry players to develop and market a patented formulation.
Swisse Wellness is in the beginning stages of a double-blind RCT on its Ultiboost High Strength Deep Sea Krill Oil, with the first four participants having recently enrolled.
Israeli astaxanthin manufacturer Algatechnologies (Algatech) has partnered with Italian R&D firm Sphera Encapsulation to produce new functional ingredient formats.
Manufacturer Matakana Superfoods is looking to establish a retail presence outside of Australia, Chile and its native New Zealand, after enjoying considerable success in the organic food segment through online sales.
Nestlé has invested US$151.3m in two new factories in China as part of its latest efforts to increase its FSMP (foods for special medical purposes) and skincare offerings.
Usana Health Sciences is planning to use social media platforms to energize its direct selling model in sluggish markets such as North America and Europe.
Daigou shoppers are believed to have accounted for $800m of 'unofficial' supplement exports from Australia to China in the past year, dwarfing the $320m figure for official exports.
Wattle Health Australia recently signed a distribution agreement with International Supplies and Distribution Company (ISDC), a Chinese firm specialising in premium food products.
Australian probiotic start-up PERKii has partnered with retail cold-chain distribution firm Manassen Foods Australia (MFA) and embarked on a trial at a number of Woolworths stores.
Confectionery company Yupi recently launched its Youvit gummy vitamin in Indonesia, and is looking to bring it to other Asian markets, such as Singapore, very soon.
Supplement giant Blackmores recorded profits of $52m for the first nine months — up 19.3% — but conceded that its performance in China during the third quarter was 'below expectations'.
